Home > Insights > boult.bites Biotech – Spring 2015
26 April, 2015

Spotlight on second medical use claims

Claims directed to new therapeutic uses of known compounds, so-called second medical use claims, have been accepted by the European Patent Office for over 30 years. It has been widely recognised that the granting of second medical use patents incentivises important medical research. However, a great deal of uncertainty surrounds the enforcement of such patents, which creates problems for pharmaceutical companies and generics manufacturers alike.

Authors

James Legg Partner

James Legg
Patent Attorney

Phone this number +44 (0)1223 883000

Email this address jlegg@boult.com

CPC4 Capital Park
Cambridge Road
Cambridge
CB21 5XE

Jennifer O'Farrell Partner Biotechnology Patent Firm

Jennifer O’Farrell
Partner

Phone this number +44 (0)20 7430 7500

Email this address jo'farrell@boult.com

Salisbury Square House
8 Salisbury Square
London
EC4Y 8AP

Joanna Peak Partner Biotechnology Patents Firm

Joanna Peak
Partner

Phone this number +44 (0)20 7430 7500

Email this address jpeak@boult.com

Salisbury Square House
8 Salisbury Square
London
EC4Y 8AP